Boston Common Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$801K Hold
53,275
0.02% 260
2025
Q1
$703K Buy
53,275
+35,210
+195% +$464K 0.02% 259
2024
Q4
$285K Buy
18,065
+3,140
+21% +$49.6K 0.01% 284
2024
Q3
$237K Hold
14,925
0.01% 302
2024
Q2
$227K Sell
14,925
-91,965
-86% -$1.4M 0.01% 306
2024
Q1
$1.57M Hold
106,890
0.04% 263
2023
Q4
$1.49M Buy
106,890
+14,450
+16% +$201K 0.03% 261
2023
Q3
$1.24M Buy
92,440
+8,675
+10% +$116K 0.03% 256
2023
Q2
$1.06M Hold
83,765
0.02% 258
2023
Q1
$954K Hold
83,765
0.02% 257
2022
Q4
$867K Hold
83,765
0.04% 171
2022
Q3
$877K Sell
83,765
-19,970
-19% -$209K 0.05% 169
2022
Q2
$1.15M Buy
103,735
+26,770
+35% +$297K 0.06% 167
2022
Q1
$858K Buy
76,965
+1,975
+3% +$22K 0.04% 177
2021
Q4
$981K Buy
74,990
+17,500
+30% +$229K 0.04% 175
2021
Q3
$749K Buy
57,490
+10,350
+22% +$135K 0.03% 182
2021
Q2
$693K Sell
47,140
-10,360
-18% -$152K 0.03% 195
2021
Q1
$706K Buy
+57,500
New +$706K 0.04% 186
2020
Q2
Sell
-81,360
Closed -$656K 220
2020
Q1
$656K Hold
81,360
0.09% 157
2019
Q4
$660K Buy
81,360
+3,360
+4% +$27.3K 0.08% 167
2019
Q3
$591K Hold
78,000
0.07% 156
2019
Q2
$585K Buy
78,000
+6,050
+8% +$45.4K 0.07% 159
2019
Q1
$583K Hold
71,950
0.08% 155
2018
Q4
$543K Buy
71,950
+10,850
+18% +$81.9K 0.08% 147
2018
Q3
$423K Hold
61,100
0.05% 168
2018
Q2
$393K Buy
+61,100
New +$393K 0.05% 165
2014
Q3
Sell
-1,125
Closed -$10K 306
2014
Q2
$10K Hold
1,125
﹤0.01% 337
2014
Q1
$10K Buy
+1,125
New +$10K ﹤0.01% 371
2013
Q4
Sell
-1,125
Closed -$9K 342
2013
Q3
$9K Hold
1,125
﹤0.01% 387
2013
Q2
$9K Buy
+1,125
New +$9K ﹤0.01% 370